Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients (22.01.2018) - Astellas Pharma Inc., Vical Incorporated
Stand: 18.06.2018